ZA200204460B - Valnemulin formulation. - Google Patents

Valnemulin formulation.

Info

Publication number
ZA200204460B
ZA200204460B ZA200204460A ZA200204460A ZA200204460B ZA 200204460 B ZA200204460 B ZA 200204460B ZA 200204460 A ZA200204460 A ZA 200204460A ZA 200204460 A ZA200204460 A ZA 200204460A ZA 200204460 B ZA200204460 B ZA 200204460B
Authority
ZA
South Africa
Prior art keywords
valnemulin
formulation
valnemulin formulation
Prior art date
Application number
ZA200204460A
Other languages
English (en)
Inventor
Kurt Koller
Franz Schwarz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200204460B publication Critical patent/ZA200204460B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA200204460A 1999-12-09 2002-06-04 Valnemulin formulation. ZA200204460B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99811128 1999-12-09

Publications (1)

Publication Number Publication Date
ZA200204460B true ZA200204460B (en) 2003-09-03

Family

ID=8243176

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200204460A ZA200204460B (en) 1999-12-09 2002-06-04 Valnemulin formulation.

Country Status (19)

Country Link
US (1) US6284792B1 (de)
EP (1) EP1235566B1 (de)
JP (1) JP3864090B2 (de)
KR (1) KR100491464B1 (de)
CN (1) CN1188122C (de)
AR (1) AR029777A1 (de)
AT (1) ATE291422T1 (de)
AU (1) AU769857B2 (de)
BR (1) BR0016262B1 (de)
CA (1) CA2390047C (de)
DE (1) DE60018967T2 (de)
DK (1) DK1235566T3 (de)
ES (1) ES2240232T3 (de)
MX (1) MXPA02005705A (de)
PT (1) PT1235566E (de)
RU (1) RU2270676C2 (de)
TW (1) TWI228048B (de)
WO (1) WO2001041758A2 (de)
ZA (1) ZA200204460B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5390081A1 (es) * 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
US6918561B2 (en) * 2002-10-31 2005-07-19 Yon So Chong Shell assembly for winding tire cord strip or belt cord strip
CN101744799B (zh) * 2008-12-12 2012-01-11 北京大北农科技集团股份有限公司 一种兽用沃尼妙林及其盐的脂质体新剂型及其制备方法
CN101947203A (zh) * 2010-10-14 2011-01-19 郑州后羿制药有限公司 一种兽用盐酸沃尼妙林乳剂及其制备方法
CN103288694B (zh) * 2013-06-28 2015-06-17 宁夏泰瑞制药股份有限公司 一种截短侧耳素类合成衍生物盐的晶体制备方法
CN103483232B (zh) * 2013-09-25 2015-05-13 宁夏泰瑞制药股份有限公司 一种盐酸沃尼妙林的精制方法
CN103520099A (zh) * 2013-10-30 2014-01-22 王玉万 含有效成份为沃尼妙林的长效注射剂
CN103705454B (zh) * 2014-01-07 2016-08-31 王玉万 含盐酸沃尼妙林/泊洛沙姆407的油质注射剂
CN104689324A (zh) * 2014-07-30 2015-06-10 王玉万 含亲水性治疗药物可乳化油质注射剂的制备方法
CN104311464A (zh) * 2014-09-15 2015-01-28 河北威远动物药业有限公司 一种兽用沃尼妙林的制备方法
KR102098289B1 (ko) * 2018-04-11 2020-04-07 경북대학교 산학협력단 발네물린을 유효성분으로 함유하는 골 질환 예방 또는 치료용 조성물
CN108635333B (zh) * 2018-07-10 2021-10-01 四川通达动物保健科技有限公司 一种盐酸沃尼妙林冻干粉针剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds

Also Published As

Publication number Publication date
BR0016262A (pt) 2002-08-13
JP3864090B2 (ja) 2006-12-27
US6284792B1 (en) 2001-09-04
DK1235566T3 (da) 2005-06-20
EP1235566B1 (de) 2005-03-23
ES2240232T3 (es) 2005-10-16
AR029777A1 (es) 2003-07-16
US20010021693A1 (en) 2001-09-13
DE60018967D1 (de) 2005-04-28
EP1235566A2 (de) 2002-09-04
PT1235566E (pt) 2005-08-31
AU769857B2 (en) 2004-02-05
MXPA02005705A (es) 2002-09-18
ATE291422T1 (de) 2005-04-15
DE60018967T2 (de) 2006-03-23
CN1409631A (zh) 2003-04-09
WO2001041758A2 (en) 2001-06-14
KR20020064335A (ko) 2002-08-07
JP2003516352A (ja) 2003-05-13
CN1188122C (zh) 2005-02-09
BR0016262B1 (pt) 2014-10-21
CA2390047C (en) 2010-03-16
AU3007701A (en) 2001-06-18
WO2001041758A8 (en) 2002-08-29
KR100491464B1 (ko) 2005-05-25
RU2270676C2 (ru) 2006-02-27
CA2390047A1 (en) 2001-06-14
WO2001041758A3 (en) 2002-03-07
TWI228048B (en) 2005-02-21

Similar Documents

Publication Publication Date Title
GB2359254B (en) Formulation
HUP0201489A3 (en) New formulation
EP1235487A4 (de) Ernaehrungszusammensetzung
AU5139600A (en) Nutritional formulations
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200108304B (en) Agrochemical formulations.
ZA200200477B (en) 2-pyrazolin-5-ones.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
EG24226A (en) Formulation
ZA200202537B (en) Pour-on-formulations.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
GB0000891D0 (en) Formulation
GB9921336D0 (en) Nutritional compositions
ZA200204460B (en) Valnemulin formulation.
GB9905898D0 (en) Controlled-dose formulation
GB9902304D0 (en) Formulation
GB9927614D0 (en) Sterliant formulation
ZA994697B (en) Pharmaceutical formulation.
ZA99918B (en) Pharmaceutical formulation.
GB9902236D0 (en) Formulation
HK1031254A1 (en) Tachogragh.
GB9923538D0 (en) Formulation
GB9915584D0 (en) Formulation
GB9908776D0 (en) Formulation
GB9917952D0 (en) Formulation